February 10, 2017
A Materials Transfer Agreement (MTA) is required for both incoming and outgoing materials. A MTA typically is required when human embryonic stem cells (hESC) are received or shared between Washington University investigators and other academic or industry partners.
An MTA or approval/authorization also may be required to obtain hESCs from the WU Genome Engineering and iPSC Center (GEic) and the Center of Regenerative Medicine hESC Core.
- Contact the Office of Technology Management to begin the MTA process. This may be done when you submit your application to ESCRO
- Send a copy of the fully signed MTA to ORIE@wustl.edu
- Stem cells may not be obtained until after the appropriate agreements are in place
A Material Transfer Agreement typically is required when human embryonic stem cells (hESC) are received or shared between Washington University investigators and other academic or industry partners.
Approval/authorization also may be required for hESCs obtained from the WU Genome Engineering and iPSC Center (GEic) and Center of Regenerative Medicine hESC Core.